Continuous infusion of interleukin-6 in sublethally irradiated mice accelerates platelet reconstitution and the recovery of myeloid but not of megakaryocytic progenitor cells in bone marrow
- PMID: 8243564
Continuous infusion of interleukin-6 in sublethally irradiated mice accelerates platelet reconstitution and the recovery of myeloid but not of megakaryocytic progenitor cells in bone marrow
Abstract
Interleukin-6 (IL-6) is a pleiotropic cytokine that enhances the maturation of megakaryocytes. In mice, in vivo treatment with IL-6 results in elevated platelet counts both in untreated animals and after myelosuppressive therapy. In this study, we assessed the effect of continuous infusion of IL-6 in sublethally irradiated (7 Gy) mice on peripheral blood cell counts and progenitor cells in bone marrow and spleen. Female Swiss mice were treated by continuous infusion with 1 or 10 micrograms IL-6 per day for 7 or 14 days. Continuous infusion of IL-6 for 7 days resulted in elevated levels of circulating IL-6 (mean: 1872 pg/mL vs. 100 pg/mL for phosphate-buffered saline [PBS]-treated controls) and in an accelerated reconstitution of platelets starting at day 12 after irradiation. In IL-6-treated animals, the 50% pretreatment platelet count was reached on day 15 vs. day 21 for irradiated controls receiving no IL-6. Treatment with IL-6 for 14 days resulted in a further increase in platelet counts, exceeding the pretreatment counts. The number of colony-forming units-megakaryocyte (CFU-Mk) was significantly elevated from day 6 to 18 in the spleen but not in bone marrow. To assess the contribution of extramedullary megakaryocytopoiesis in the spleen to IL-6-induced platelet recovery, IL-6 was also administered to splenectomized mice. The stimulatory effect of IL-6 on platelet recovery was preserved in these animals, indicating that megakaryocytopoiesis in the spleen did not contribute to the accelerated recovery of platelets. The neutrophil counts were elevated during IL-6 treatment and became similar to controls after cessation of therapy, whereas the numbers of colony-forming units-granulocyte/macrophage (CFU-GM) in the bone marrow were elevated from day 9 to 24 in all animals treated with 10 micrograms IL-6 per day. In conclusion, continuous infusion of IL-6 stimulates platelet recovery after irradiation without increasing the number of CFU-Mk and conversely stimulates the proliferation of myeloid progenitor cells without an effect on neutrophil reconstitution.
Similar articles
-
Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.Exp Hematol. 1995 Dec;23(14):1520-6. Exp Hematol. 1995. PMID: 8542941
-
Leukemia inhibitory factor induces in vivo expansion of bone marrow progenitor cells that accelerate hematopoietic reconstitution but do not enhance radioprotection in lethally irradiated mice.Stem Cells. 1997;15(1):50-5. doi: 10.1002/stem.150050. Stem Cells. 1997. PMID: 9007222
-
Thrombopoietic effects of interleukin-6 in long-term administration in mice.Exp Hematol. 1993 May;21(5):640-6. Exp Hematol. 1993. PMID: 8513864
-
Do the preclinical effects of thrombopoietin correlate with its in vitro properties?Stem Cells. 1996;14 Suppl 1:108-11. doi: 10.1002/stem.5530140713. Stem Cells. 1996. PMID: 11012209 Review.
-
Preclinical biology of interleukin 11: a multifunctional hematopoietic cytokine with potent thrombopoietic activity.Stem Cells. 1995 Sep;13(5):462-71. doi: 10.1002/stem.5530130503. Stem Cells. 1995. PMID: 8528095 Review.
Cited by
-
Platelets accumulate in lung lesions of tuberculosis patients and inhibit T-cell responses and Mycobacterium tuberculosis replication in macrophages.Eur J Immunol. 2022 May;52(5):784-799. doi: 10.1002/eji.202149549. Epub 2022 Apr 9. Eur J Immunol. 2022. PMID: 35338775 Free PMC article.
-
Platelet turnover in stable coronary artery disease - influence of thrombopoietin and low-grade inflammation.PLoS One. 2014 Jan 21;9(1):e85566. doi: 10.1371/journal.pone.0085566. eCollection 2014. PLoS One. 2014. PMID: 24465602 Free PMC article.
-
The molecular mechanisms that control thrombopoiesis.J Clin Invest. 2005 Dec;115(12):3339-47. doi: 10.1172/JCI26674. J Clin Invest. 2005. PMID: 16322778 Free PMC article. Review.
-
Toxicities Associated with Systemic Administration of Interleukin-6 in Wistar Albino Rats.J Exp Pharmacol. 2025 Aug 8;17:545-554. doi: 10.2147/JEP.S529995. eCollection 2025. J Exp Pharmacol. 2025. PMID: 40799355 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical